Skip to search formSkip to main contentSkip to account menu

MK 927

Known as: MK 0927, MK-0927, MK-927 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
MK-927 [5,6-dihydro-4H-4(isobutylamino)thieno(2,3-B)thiopyran-2-sulfonamide-7.7 dioxide], a potent carbonic anhydrase inhibitor… 
1991
1991
A new topically administered anhydrase inhibitor, MK-927, was evaluated for its ocular hypotensive activity in normotensive and… 
1991
1991
The multiple-dose, dose-response curve of MK-927 was studied in a five-center, double-masked, randomized, placebo-controlled… 
1991
1991
Potential systemic effects of the racemic carbonic anhydrase inhibitor MK‐927 and its S‐enantiomer, sezolamide hydrochloride… 
1990
1990
The dose response to a single topical administration of the carbonic anhydrase inhibitor MK-927 was investigated in 24 patients… 
1990
1990
MK-927 (dl-5,6-dihydro-4-(2-methylpropylamino)-4H-thieno(2,3b)thiopyra n-2-sulfonamide-7,7-dioxide hydrochloride) is a water… 
1990
1990
We investigated the dose-response and reproducibility of the intraocular pressure-lowering effect of MK-927 in ocular… 
1990
1990
MK-927 is a water soluble, potent inhibitor of human carbonic anhydrase (CA) II in vitro. Topical administration of MK-927… 
1989
1989
The effects on intraocular pressure of the novel topical carbonic anhydrase inhibitor MK-927 were investigated for the first time… 
1988
1988
A three-dose, randomized, double-masked, parallel, placebo-controlled ocular tolerance study was undertaken in 12 healthy, normal…